CDMO News
Almac New Capability: Therapeutic Oligonucleotides Synthesis
Almac Sciences, a member of the Almac Group, has announced a new capability to synthesise therapeutic oligonucleotides. This has been made possible by the introduction of a new RNA Ligase (RNAL) enzyme kit that extends the company’s selectAZyme™ enzyme screening